Matches in Wikidata for { <http://www.wikidata.org/entity/Q66403705> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q66403705 description "clinical trial" @default.
- Q66403705 description "ensayu clínicu" @default.
- Q66403705 description "klinisch onderzoek" @default.
- Q66403705 description "клінічне випробування" @default.
- Q66403705 description "կլինիկական փորձարկում" @default.
- Q66403705 name "Treatment of Macrophage Activation Syndrome (MAS) With Anakinra" @default.
- Q66403705 name "Treatment of Macrophage Activation Syndrome" @default.
- Q66403705 type Item @default.
- Q66403705 label "Treatment of Macrophage Activation Syndrome (MAS) With Anakinra" @default.
- Q66403705 label "Treatment of Macrophage Activation Syndrome" @default.
- Q66403705 prefLabel "Treatment of Macrophage Activation Syndrome (MAS) With Anakinra" @default.
- Q66403705 prefLabel "Treatment of Macrophage Activation Syndrome" @default.
- Q66403705 P1050 Q66403705-33302C0E-7CD3-4698-A77B-DF9F49B386E2 @default.
- Q66403705 P1132 Q66403705-30CA96BC-E8F0-4571-A553-C1148287E1A1 @default.
- Q66403705 P1476 Q66403705-A9706519-C938-4D44-B0DA-9C6AA9674797 @default.
- Q66403705 P17 Q66403705-DBF61D28-DD87-40EC-B9A6-3C329F9FCFB5 @default.
- Q66403705 P1813 Q66403705-C67D731F-20BA-4631-B942-8613E302C7A4 @default.
- Q66403705 P3098 Q66403705-74739935-56EE-4D5A-BF0F-466A3DD863DB @default.
- Q66403705 P31 Q66403705-8F066EE7-ED5B-4F48-8088-DDA0959CB72A @default.
- Q66403705 P4844 Q66403705-01D9E102-10D1-495E-89E7-71D2B3C5A9B1 @default.
- Q66403705 P4844 Q66403705-065D1831-728E-47A6-95B7-B03ADC9FC683 @default.
- Q66403705 P4844 Q66403705-3A3A0468-DC76-4A45-BDDC-9FD221D3ABD0 @default.
- Q66403705 P4844 Q66403705-3B0AD62F-E167-4626-ABFF-65FAF24976EF @default.
- Q66403705 P4844 Q66403705-7E7E6317-716E-421F-800C-29DF56BEAEEC @default.
- Q66403705 P580 Q66403705-8E7D5FE3-0764-4284-93D2-34944D20FD30 @default.
- Q66403705 P582 Q66403705-AF791685-AB56-4C0C-A140-15ABEB3B409C @default.
- Q66403705 P6099 Q66403705-91866931-76B4-47FA-8740-37A26B61A63F @default.
- Q66403705 P8363 Q66403705-2CDCC2E4-202C-49CE-8744-966692ED096C @default.
- Q66403705 P1050 Q179630 @default.
- Q66403705 P1132 "+40" @default.
- Q66403705 P1476 "Randomized Placebo Controlled Trial of Subcutaneous rhIL-1A (Anakinra) in the Management of Hospitalized Pediatric and Adult Patients With Macrophage Activation Syndrome" @default.
- Q66403705 P17 Q30 @default.
- Q66403705 P1813 "MAS" @default.
- Q66403705 P3098 "NCT02780583" @default.
- Q66403705 P31 Q30612 @default.
- Q66403705 P4844 Q11426176 @default.
- Q66403705 P4844 Q27108063 @default.
- Q66403705 P4844 Q27262132 @default.
- Q66403705 P4844 Q27266327 @default.
- Q66403705 P4844 Q417222 @default.
- Q66403705 P580 "2016-05-01T00:00:00Z" @default.
- Q66403705 P582 "2019-06-01T00:00:00Z" @default.
- Q66403705 P6099 Q5452194 @default.
- Q66403705 P8363 Q78089383 @default.